ciprofloxacin has been researched along with Anti-Phospholipid Antibody Syndrome in 1 studies
Ciprofloxacin: A broad-spectrum antimicrobial carboxyfluoroquinoline.
ciprofloxacin : A quinolone that is quinolin-4(1H)-one bearing cyclopropyl, carboxylic acid, fluoro and piperazin-1-yl substituents at positions 1, 3, 6 and 7, respectively.
Excerpt | Relevance | Reference |
---|---|---|
"A decrease in the incidence of pregnancy loss and an improvement in the clinical manifestations of APS were noted in the mice treated with ciprofloxacin, compared with the mice given ceftazidime." | 7.70 | Ciprofloxacin immunomodulation of experimental antiphospholipid syndrome associated with elevation of interleukin-3 and granulocyte-macrophage colony-stimulating factor expression. ( Barak, V; Blank, M; Fishman, P; George, J; Koike, T; Levy, Y; Savion, S; Shoenfeld, Y; Toder, V, 1998) |
"A decrease in the incidence of pregnancy loss and an improvement in the clinical manifestations of APS were noted in the mice treated with ciprofloxacin, compared with the mice given ceftazidime." | 3.70 | Ciprofloxacin immunomodulation of experimental antiphospholipid syndrome associated with elevation of interleukin-3 and granulocyte-macrophage colony-stimulating factor expression. ( Barak, V; Blank, M; Fishman, P; George, J; Koike, T; Levy, Y; Savion, S; Shoenfeld, Y; Toder, V, 1998) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Blank, M | 1 |
George, J | 1 |
Fishman, P | 1 |
Levy, Y | 1 |
Toder, V | 1 |
Savion, S | 1 |
Barak, V | 1 |
Koike, T | 1 |
Shoenfeld, Y | 1 |
1 other study available for ciprofloxacin and Anti-Phospholipid Antibody Syndrome
Article | Year |
---|---|
Ciprofloxacin immunomodulation of experimental antiphospholipid syndrome associated with elevation of interleukin-3 and granulocyte-macrophage colony-stimulating factor expression.
Topics: Adjuvants, Immunologic; Animals; Anti-Infective Agents; Antibody Formation; Antiphospholipid Syndrom | 1998 |